Authors
Latest:
Advancing Epilepsy Research Through Implementation Science and Biomarkers: Adam Numis, MD; Laura Kirkpatrick, MDAt AES 2024, a duo of pediatric epilepsy specialists discussed how implementation science, validated blood biomarkers, and cross-disciplinary collaboration are advancing epilepsy care and closing research gaps. [WATCH TIME: 3 minutes]
Latest:
Next Steps for ATA188, Research Related to EBV and Multiple Sclerosis: AJ Joshi, MDThe chief medical officer at Atara Biotherapeutics provided insight on the future direction of its investigational agent ATA188 following new data that suggested a link between Epstein-Barr virus and multiple sclerosis. [WATCH TIME: 4 minutes]
Latest:
Future Research on Cannabis Use to Treat Migraine: Nathaniel Schuster, MDThe pain management specialist and headache neurologist at the University of California San Diego Center for Pain Medicine discussed the different forms of cannabis and the need to conduct larger, multicenter studies to better understand its effects in migraine. [WATCH TIME: 3 minutes]
Latest:
Lifting Barriers to Equitable Care in EpilepsyFour neurologists treating patients with epilepsy share their experience in and out of the clinic tackling issues of access for their patients.
Latest:
The Changing Landscape of Preventative Migraine TreatmentsA panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Latest:
AUPN Leadership Minute Episode 9: Engaging Medical Students in Neurology – Part 2Episode 9 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the Veterans Health Administration; and Douglas J. Gelb, MD, PhD, of the University of Michigan [WATCH TIME: 5 minutes]
Latest:
The Evolving Diagnostic Criteria for Multiple SclerosisJoin Ahmed Obeidat, MD, PhD; Hesham Abboud, MD, PhD; and Rana K. Zabad, MD, FAAN, for perspectives on how the diagnostic criteria for multiple sclerosis have evolved over time.
Latest:
Building a Greater Understanding for NMOSD Treatments, Neurodegeneration: John Chen, MD, PhDThe neuroophtalmologist at Mayo Clinic detailed improvements in prescribing methods for NMOSD treatments and the conversations surrounding reversing neurodegeneration. [WATCH TIME: 3 minutes]
Latest:
The Unresolved Bottleneck of Accessing Care for Mental Health in MS: Bernd C. Kieseier, MDThe global program head of the development unit for neuroscience at Novartis talked about the evolving landscape of mental health care for multiple sclerosis including the accessibility barrier that remains for patients in many regions. [WATCH TIME: 4 minutes]
Latest:
Promising Preclinical Evidence of Skeletal Muscle Regenerator SAT-3247: Frank GleesonThe president and chief executive officer of Satellos Bioscience provided an overview of the previously observed preclinical data supporting SAT-3247 as a potential therapy for muscular dystrophies. [WATCH TIME: 4 minutes]
Latest:
Assessing the Felix NeuralAI Wristband for Essential Tremor Management: Zhen Zhang, PhD, & Rajesh Pahwa, MDThe president at Fasikl and the Laverne and Joyce Rider professor of neurology at the University of Kansas Medical Center talked about results from a pilot study assessing the Felix Neural AI wristband in patients with essential tremor. [WATCH TIME: 4 minutes]
Latest:
Insights From Comprehensive Research on Epilepsy and Cognitive Decline: Ifrah Zawar, MDThe assistant professor of neurology at the University of Virginia talked about findings from a comprehensive study on epilepsy and mild cognitive impairment, which was recently presented at AES 2023. [WATCH TIME: 5 minutes]
Latest:
Air Pollution’s Impact on Cognitive Decline and the Neurotoxicity of Particulate Matter: Masashi Kitazawa, PhDThe associate professor of environmental and occupational Health at the University of California, Irvine, talked about the impact of concentrated particulate matter or air pollution on cognitive function in animal models. [WATCH TIME: 5 minutes]
Latest:
Preventing Secondary Stroke: Practical Application of Updated GuidelinesExperts provide a summary of the management of commonly encountered risk factors for secondary ischemic stroke and transient ischemic attack based on the newly published 2021 AHA/ASA recommendations.
Latest:
How Vidofludimus Calcium Addresses Unmet Treatment Needs in Multiple Sclerosis: Andreas Muehler, MD, MBAThe chief medical officer at Immunic provided clinical insight on the dual mechanism of action of vidofludimus calcium, and how its positioned as a treatment option across all MS subtypes. [WATCH TIME: 3 minutes]
Latest:
Challenges in Transitioning Care for Duchenne Muscular Dystrophy: Diana Castro, MDThe neuromuscular specialist at the Neurology & Neuromuscular Care Center discussed the pressing need to address the transition of care from pediatric to adult healthcare systems in Duchenne muscular dystrophy. [WATCH TIME: 6 minutes]
Latest:
Physical Therapy, Optimizing Function in Neuromuscular Diseases: Megan Iammarino, PT, DPTThe research physical therapist at Nationwide Children’s Hospital talked about the role of physical therapy in the changing landscape of care with neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 5 minutes]
Latest:
Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.
Latest:
Characterizing Real-World Outcomes With Eptinezumab in Migraine: Zubair Ahmed, MDThe neurologist from Cleveland Clinic discussed the importance of studying real-world outcomes in patients with migraine using CGRPs such as eptinezumab.
Latest:
The Future of Multiple Sclerosis TreatmentAhmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, share their hopes about the evolution of future mutiple sclerosis care and express their gratitude for the next generation of neurologists.
Latest:
The Paradigm Shift in Therapeutic Intervention for ALS: Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMSThe Bushell Chair of Neurology at the University of Sydney offered his perspective on phase 2 data of CNM-Au8 in amyotrophic lateral sclerosis and spoke to the advances that the field has made in recent years. [WATCH TIME: 3 minutes]
Latest:
Understanding Brain Differences in MRI Markers, Sleep-Disordered Breathing of Latino Individuals: Alberto Ramos, MD, MSPH, FAASMThe director of the Sleep Disorders program at the University of Miami discussed his research regarding the association of sleep disordered breathing and total brain volumes in Latino individuals. [WATCH TIME: 3 minutes]
Latest:
Efforts to Overcome Sleep Issues in Underserved Communities: Dayna Johnson, PhD, MPH, MSW, MSThe sleep epidemiologist and assistant professor at the Rollins School of Public Health at Emory University discussed the multi-level effort needed to improve sleep issues seen in individuals most impacted by social determinants of health. [WATCH TIME: 3 minutes]
Latest:
Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ CongressClinicians must be armed with fact-based information on all treatment options especially newer medications and technologies—good clinical care must be both patient-centric and knowledge-driven.
Latest:
Curving Complications Associated With Narcolepsy: Mihaela Nowak, MDThe neurologist and sleep disorder specialist at Allegheny Health Network discussed the challenges with preventing narcolepsy and the strategies patients can take to improve their overall prognosis. [WATCH TIME: 4 minutes]
Latest:
AUPN Leading Edge Episode 3: What Your CEO Wants From YouAUPN Leading Edge Episode 3 features Clifton Gooch, MD, and Rich Sobieray, who discuss expectations for chairs in the academic health systems. [LISTEN TIME: 37 minutes]
Latest:
Managing Insomnia: Practical Advice for Community PhysiciansClosing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Latest:
Evolving Rehabilitation Strategies for Multiple SclerosisAhmed Obeidat, MD, PhD; Francois Bethoux, MD; and Nicholas C. Ketchum, MD, discuss recent advancements and future directions in rehabilitation strategies for multiple sclerosis.
Latest:
The Benefits of a New Therapy for Pompe Disease: Tahseen Mozaffar, MD, FAANOn Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]
Latest:
The Relationship Between Epstein-Barr Virus and Multiple SclerosisThe paradigm-shifting evidence of the link between MS and EBV does not exist in isolation. In fact, the relationship has been suspected for more than 40 years, and evidence therein has been accumulating over the past 2 decades.
